Pharmacology

OnabotulinumtoxinA for Bladder Problems; Older Cancer Patients Not Getting Full Treatment; Vitamin B Reduces Diabetic Neuropathy

OnabotulinumtoxinA is thought of mostly as a treatment for facial wrinkles, but it's also approved for other medical conditions, including cervical dystonia; chronic migraine; and now, overactive bladder (OAB), a condition in which the bladder squeezes too often or without warning. OnabotulinumtoxinA, injected into the bladder, blocks the transmission of nerve impulses to the bladder muscle, calming contractions, which helps increase the bladder's storage capacity. It also reduces episodes of urinary incontinence.


 

Recommended Reading

Oncologist Communication Feedback Improves Patient Trust
AVAHO
A Brighter Prognosis in Nonalcoholic Fatty Liver Disease
AVAHO
Posterior Reversible Encephalopathy Syndrome as a Complication of Chemotherapy
AVAHO
CLEOPATRA Study and MBC
AVAHO
Diabetes May Increase Risk of Cancer Death
AVAHO
Clinical Trial List for Cancer
AVAHO
Burn Scar Carcinoma: Patients With Marjolin's Ulcer
AVAHO
Evaluation of Vitamin D Supplementation in a Veteran Population
AVAHO
Vitamin D Deficiency
AVAHO
Venous Thromboembolism and Weight Changes in Veteran Patients Using Megestrol Acetate as an Appetite Stimulant
AVAHO